搜索结果: 'methocult media formulations for human hematopoietic cells serum containing'

Re-Creating Disease with Kidney Organoids and CRISPR In this webinar, Dr. Benjamin Freedman from the University of Washington provides an overview of re-creating disease using kidney organoids and CRISPR-Cas9 genome editing. As a postdoctoral fellow in the Renal Division at Brigham and Women’s Hospital at Harvard Medical School, Dr. Freedman was responsible for several innovative techniques that he describes in this webinar, including differentiation of human pluripotent stem cells (hPSCs) into kidney organoids containing nephron-like segments and generating knockout mutations in organoids with CRISPR.

Coating Plates with Matrigel® for Pluripotent Stem Cell Culture Culturing and maintaining human ESCs and iPSCs with mTeSR™1 (Catalog #5850) or TeSR™2 (Catalog #05860) requires tissue culture plates coated with a matrix

Initiating Intestinal Organoid Differentiation from Single-Cell hPSCs Using STEMdiff™

mTeSR™3D for Expansion and Scale Up of Human Pluripotent Stem Cell Cultures

Increased Single-Cell Cloning Efficiency of Human Pluripotent Stem Cells Using CloneR™

Reliable In Vitro Culture Solutions for Your Alveolar Research

“Manipulating Stem Cell Fate” Featuring Dr. Shuibing Chen On this episode of the Stem Cell Podcast, Dr. Shuibing Chen from Weill Cornell Medicine talks about using organoids to study diabetes, Zika, and SARS-CoV-2.

Selection of SSEA4+ Human Pluripotent Stem Cells from a Mixed Population .

Defined Culture Conditions for Efficient Derivation Expansion and Cryopreservation of Mesenchymal Progenitor Cells from Human Pluripotent Stem Cells

Comparison of Human Pluripotent Stem Cells Cultured on Matrigel™ and Recombinant Human Vitronectin Using TeSR™-E8™ Low Protein Medium .

Generation of Microglia From Human Pluripotent Stem Cells for Neurodegenerative Disease Modeling

Stirred Suspension Culture of Human Pluripotent Stem Cells in mTeSR™1 Medium .